Definite/probable scaffold thrombosis (ST)
ST is assessed per the Academic Research Consortium (ARC) definite/probable definition.
The annual rate of definite/probable scaffold thrombosis
ST is assessed per the Academic Research Consortium (ARC) definite/probable definition.
The annual rate of definite/probable scaffold thrombosis
ST is assessed per the Academic Research Consortium (ARC) definite/probable definition.
The annual rate of definite/probable scaffold thrombosis
ST is assessed per the Academic Research Consortium (ARC) definite/probable definition.
Percentage of very small vessels (per-lesion basis)
This is the commercial Training Assessment Endpoint (Angiographic Subgroup only). Pre-procedure reference vessel diameter (RVD) < 2.25 mm as assessed by core laboratory using quantitative coronary angiography (QCA).
Death (Cardiac, Non-Cardiac)
Cardiac death (CD): Any death due to proximate cardiac cause (e.g. MI, low-output failure, fatal arrhythmia), unwitnessed death and death of unknown cause, all procedure related deaths including those related to concomitant treatment.
Non-cardiovascular death: Any death not covered by the above definitions such as death caused by infection, malignancy, sepsis, pulmonary causes, accident, suicide or trauma.
Death (Cardiac, Non-Cardiac)
Death (Cardiac, Non-Cardiac)
Death (Cardiac, Non-Cardiac)
Death (Cardiac, Non-Cardiac)
Death (Cardiac, Non-Cardiac)
All Myocardial Infarction (All MI)
All Myocardial Infarction (All MI)
All Myocardial Infarction (All MI)
All Myocardial Infarction (All MI)
All Myocardial Infarction (All MI)
All Myocardial Infarction (All MI)
Target Lesion Revascularization (TLR)
TLR is defined as any repeat percutaneous intervention of the target lesion or bypass surgery of the target vessel performed for restenosis or other complication of the target lesion.
Target Lesion Revascularization (TLR)
Target Lesion Revascularization (TLR)
Target Lesion Revascularization (TLR)
Target Lesion Revascularization (TLR)
Target Lesion Revascularization (TLR)
Ischemia Driven TLR (ID-TLR)
TLR is defined as any repeat percutaneous intervention of the target lesion or bypass surgery of the target vessel performed for restenosis or other complication of the target lesion.
Ischemia Driven TLR (ID-TLR)
Ischemia Driven TLR (ID-TLR)
Ischemia Driven TLR (ID-TLR)
Ischemia Driven TLR (ID-TLR)
Ischemia Driven TLR (ID-TLR)
Target Vessel Revascularization (TVR)
TVR is defined as any repeat percutaneous intervention or surgical bypass of any segment of the target vessel. The target vessel is defined as the entire major coronary vessel proximal and distal to the target lesion which includes upstream and downstream branches and the target lesion itself.
Target Vessel Revascularization (TVR)
Target Vessel Revascularization (TVR)
Target Vessel Revascularization (TVR)
Target Vessel Revascularization (TVR)
Target Vessel Revascularization (TVR)
All coronary revascularization
All coronary revascularization
All coronary revascularization
All coronary revascularization
All coronary revascularization
All coronary revascularization
Scaffold thrombosis (per ARC definition)
Scaffold/Stent thrombosis should be reported as a cumulative value at the different time points and with the different separate time points. Time 0 is defined as the time point after the guiding catheter has been removed and the subject left the catheterization lab.
Timings:
Acute scaffold/stent thrombosis : 0 - 24 hours post stent implantation Subacute scaffold/stent thrombosis: >24 hours - 30 days post stent implantation Late scaffold/stent thrombosis: 30 days - 1 year post stent implantation Very late scaffold/stent thrombosis: >1 year post stent implantation
Scaffold thrombosis (per ARC definition)
Scaffold thrombosis (per ARC definition)
Scaffold thrombosis (per ARC definition)
Death/All Myocardial Infarction (MI)
All deaths are considered cardiac unless an unequivocal non-cardiac cause can be established. Specifically, any unexpected death even in patients with coexisting potentially fatal non-cardiac disease (e.g. cancer, infection) should be classified as cardiac.
Death/All Myocardial Infarction (MI)
Death/All Myocardial Infarction (MI)
Death/All Myocardial Infarction (MI)
Death/All Myocardial Infarction (MI)
Death/All Myocardial Infarction (MI)
Cardiac Death/All Myocardial Infarction (MI)
Cardiac death (CD): Any death due to proximate cardiac cause (e.g. MI, low-output failure, fatal arrhythmia), unwitnessed death and death of unknown cause, all procedure related deaths including those related to concomitant treatment.
Cardiac Death/All Myocardial Infarction (MI)
Cardiac Death/All Myocardial Infarction (MI)
Cardiac Death/All Myocardial Infarction (MI)
Cardiac Death/All Myocardial Infarction (MI)
Cardiac Death/All Myocardial Infarction (MI)
Cardiac Death/All Myocardial Infarction (MI)/Target vessel revascularization (TVR) [Target vessel failure;TVF]
Cardiac Death/All Myocardial Infarction (MI)/Target vessel revascularization (TVR) [TVF]
Cardiac Death/All Myocardial Infarction (MI)/Target vessel revascularization (TVR) [TVF]
Cardiac Death/All Myocardial Infarction (MI)/Target vessel revascularization (TVR) [TVF]
Cardiac Death/All Myocardial Infarction (MI)/Target vessel revascularization (TVR) [TVF]
Cardiac Death/All Myocardial Infarction (MI)/Target vessel revascularization (TVR) [TVF]
Cardiac Death/TV MI/ID-TLR (Target lesion failure;TLF)
Cardiac Death/TV MI/ID-TLR (TLF)
Cardiac Death/TV MI/ID-TLR (TLF)
Cardiac Death/TV MI/ID-TLR (TLF)
Cardiac Death/TV MI/ID-TLR (TLF)
Cardiac Death/TV MI/ID-TLR (TLF)
Death/All Myocardial Infarction (MI)/All revascularization
Death/All Myocardial Infarction (MI)/All revascularization
Death/All Myocardial Infarction (MI)/All revascularization
Death/All Myocardial Infarction (MI)/All revascularization
Death/All Myocardial Infarction (MI)/All revascularization
Death/All Myocardial Infarction (MI)/All revascularization